NCT00942591View on ClinicalTrials.gov

Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b

PHASE2CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions
Multiple Sclerosis
Interventions
DRUG

Interferon beta 1b

DRUG

Atorvastatin

Trial Locations (1)

3010

Prof. H. Mattle, Dep. of Neurology, Bern University Hospital, Bern

Sponsors

Collaborators (1)

PharmaPart
All Listed Sponsors
collaborator

PharmaPart

INDUSTRY

collaborator

Laboratory: Viollier AG Spalenring 145 / 147 Postfach 4002 Basel

UNKNOWN

lead

Insel Gruppe AG, University Hospital Bern

OTHER